Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael Prisant

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|March 31, 2004
Clinical trials and lipid guidelines for type II diabetesL Michael Prisant
Journal of Clinical Hypertension (Greenwich, Conn.)|April 30, 2005
Hypertensive heart diseaseL Michael Prisant
Current Hypertension Reports|August 4, 2006
Phosphodiesterase-5 inhibitors and their hemodynamic effectsL Michael Prisant
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|May 9, 2002
Fixed low-dose combination in first-line treatment of hypertensionL Michael Prisant
The American Journal of Medicine|July 22, 2008
Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agentsL Michael Prisant
Journal of Clinical Hypertension (Greenwich, Conn.)|July 31, 2002
Calcium channel blocker induced gingival overgrowthL Michael Prisant, Wayne Herman
Journal of Clinical Hypertension (Greenwich, Conn.)|April 30, 2005
Gynecomastia and hypertensionL Michael Prisant, Edward Chin
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
Antihypertensive pharmacobezoarL Michael Prisant, Vernon C Spaulding
Clinical Pharmacokinetics|August 12, 2003
Drug delivery systems for treatment of systemic hypertensionL Michael Prisant, William J Elliott
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Polycystic kidney diseasePamela J Fall, L Michael Prisant
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|March 31, 2004
Clinical trials and lipid guidelines for type II diabetesL Michael Prisant
Journal of Clinical Hypertension (Greenwich, Conn.)|April 30, 2005
Hypertensive heart diseaseL Michael Prisant
Current Hypertension Reports|August 4, 2006
Phosphodiesterase-5 inhibitors and their hemodynamic effectsL Michael Prisant
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|May 9, 2002
Fixed low-dose combination in first-line treatment of hypertensionL Michael Prisant
The American Journal of Medicine|July 22, 2008
Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agentsL Michael Prisant
Journal of Clinical Hypertension (Greenwich, Conn.)|July 31, 2002
Calcium channel blocker induced gingival overgrowthL Michael Prisant, Wayne Herman
Journal of Clinical Hypertension (Greenwich, Conn.)|April 30, 2005
Gynecomastia and hypertensionL Michael Prisant, Edward Chin
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
Antihypertensive pharmacobezoarL Michael Prisant, Vernon C Spaulding
Clinical Pharmacokinetics|August 12, 2003
Drug delivery systems for treatment of systemic hypertensionL Michael Prisant, William J Elliott
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Polycystic kidney diseasePamela J Fall, L Michael Prisant
Pageof 6